Teva might have been better off as a smaller company, new CEO says. The generic drugs powerhouse is now carrying a $34.7 billion debta result of a $40.5 acquisition of Actavis. New CEO Kåre Schultz presented a detailed restructuring plan on Thursday. Read more
Israel goes on strike in support of Teva employees. On Sunday, Israels main airport, banks, hospitals and government offices went on strike in support of Teva employees in the country, many of them slated for layoffs according to the companys announced restructuring plan. Read more
Teva wants to be like Mylan, says Israeli economist. The cost-cutting plan revealed Thursday by Teva CEO Kåre Schultz showcases an intention to transform Teva into a lean and efficient g…
Read the full article at: https://www.calcalistech.com/ctech/articles/0,7340,L-3727549,00.html